Advanced Biomed (ADVB) Total Non-Current Liabilities (2024 - 2026)

Advanced Biomed has reported Total Non-Current Liabilities for 3 years, with the latest figure at $10903.0 in Q1 2026.

• Quarterly Total Non-Current Liabilities fell 75.48% year-over-year to $10903.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10903.0 (down 75.48% YoY) and the FY2025 annual result came in at $145651.0, up 125.71% from the prior year.
• Total Non-Current Liabilities slipped to $10903.0 in Q1 2026 per ADVB's latest filing, from $115496.0 in the prior quarter.
• Over five years, Total Non-Current Liabilities peaked at $193894.0 in Q3 2025 and troughed at $10903.0 in Q1 2026.
• A 3-year average of $90181.6 and a median of $64529.0 in 2024 frame the typical range for Total Non-Current Liabilities.
• The sharpest annual moves came in 2025 and 2026: Total Non-Current Liabilities jumped 125.71% in 2025, then plunged 75.48% in 2026.
• Over 3 years, Total Non-Current Liabilities stood at $56326.0 in 2024, then surged by 105.05% to $115496.0 in 2025, then sank by 90.56% to $10903.0 in 2026.
• According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $10903.0, $115496.0, and $193894.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.